Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Agency: National Institutes of Health
Assistance Listings: 93.866 -- Aging Research
93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
Last Updated: November 26, 2024
Description
This Funding Opportunity Announcement (FOA) invites applications to the National Institute on Aging's (NIA) Small Business Technology Transfer Research (STTR) program. The aim of this FOA is to support research that may lead to the development of innovative products and/or services with the potential to advance progress in preventing and treating Alzheimer's disease (AD) and AD-related dementias (ADRD) and/or caring for and treating patients living with AD/ADRD.
Eligibility
Eligible applicants
Business
- Small businesses
Additional information
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Grantor contact information
Description
NIH OER Webmaster
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Documents
No documents are currently available.
Link to additional information
Archived: October 11, 2025
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$1,838,436
Award Maximum
Funding opportunity number:
PAS-22-197
Cost sharing or matching requirement:
No
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
--
Category of Funding Activity:
Health
Category Explanation:
--
History
Version:
1
Posted date:
June 21, 2022
Archive date:
October 11, 2025
